Cardiac morbidity and related mortality in children with HIV infection
Article Abstract:
Adverse cardiac events appear to increase among children infected with HIV as the disease progresses. Heart function was assessed among 81 young children infected with HIV. Elevated heart rate, which was seen in 52 (64%) of the children, was the most common heart abnormality. An abnormally slow heart rate was noted in nine (11%) of the children. Fifteen of the children had high blood pressure, and 16 had low blood pressure. Dysrhythmia, which is an abnormality in the heart rhythm, occurred in 28 (35%) of the children. Seven children experienced cardiac arrest, and eight had congestive heart failure. Heart abnormalities were more severe and more frequent in children with advanced HIV disease. Heart dysfunction was associated with death in 10 of the 37 children who died. Encephalopathy, which is degeneration of the brain, was the strongest predictor of cardiac arrest, and infection with Epstein-Barr virus was the strongest predictor of the development of congestive heart failure.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer
Article Abstract:
The risk of heart abnormalities caused by doxorubicin in survivors of childhood cancer appears to be highest in females and patients who received higher cumulative doses of the drug. Researchers analyzed electrocardiograms of 62 females and 58 males who had received at least 244 milligrams of doxorubicin per square meter of body-surface area. The patients had been treated for acute lymphoblastic leukemia or osteogenic sarcoma, and their treatment had ended at least 2 years before evaluation. Female patients had weaker heart contractility and lower left ventricular mass than male patients. Patients who had received higher cumulative doses also had abnormal heart function. Longer time since treatment, younger age at diagnosis, and higher doxorubicin dose all increased the risk of thinning of the ventricular walls and reduced mass.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Incidence, causes and outcomes of dilated cardiomyopathy in children
Article Abstract:
Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy in children and its incidence, causes and outcomes were studied with the help of data from 2 cohorts of children with primary DCM. It is reported that there was a higher risk in boys than in girls, in African American than in white children and in infants than in children. The important identifiable causes were myocarditis and neuromuscular disease and outcomes were influenced by age, heart failure status at diagnosis and cause.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The impact of comorbid and sociodemographic factors on access to renal transplantation. Deceased-donor characteristics and the survival benefit of kidney transplantation
- Abstracts: Diagnostic value of blood sampling in fetuses with growth retardation. Maternal concentrations and fetal-maternal concentration differences of plasma amino acids in normal and intrauterine growth-restricted pregnancies
- Abstracts: Radiographic progression of hospital referred osteoarthritis of the hip. Factors affecting radiographic progression of knee osteoarthritis
- Abstracts: Hemodynamic and fluid responses to furosemide infusion in the ovine fetus. Regulation of amniotic fluid volume by intramembranous absorption in sheep: role of passive permeability and vascular endothelial growth factor
- Abstracts: Combined oral contraception with desogestrel/ethinyl estradiol: tolerability profile. Contraceptive efficacy of a monophasic oral contraceptive containing desogestrel